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Dr Yolonda Colson (Boston, Mass). You are to be commended
for your analysis of IHM and LOS in approximately 20,000 patients
undergoing lobectomy in Canada during a time of transition to re-
gionalization of thoracic surgical services. Your study demon-
strates an impressive 45% relative risk reduction in IHM and
a 19% reduction in LOS that was associated with an increased num-
ber of cases being performed at large-volume centers, alluding to
the benefits of regionalization. Although an increase in the number
of cases within a hospital did decrease LOS, it did not lead to a de-
crease in mortality, suggesting that an increase in volume alone is
not the sole answer.
In an attempt to better understand these observations and their
applicability to other scenarios and health care systems, I have
3 questions based on your presentation and article.762 The Journal of Thoracic and Cardiovascular SurgFirst, would you please describe how regionalization was initi-
ated and carried out in Canada, because we are not as familiar
with that, and how it relates to the data that you presented? For ex-
ample, was the transition gradual or does a conscious mandated
shift of patients to large-volume centers account for the abrupt in-
crease in the percentage of cases done at high-volume centers that
starts in about 2005 as demonstrated in your article, and can you
comment on the driving force behind the marked increase in the
number of lobectomies that you noted starting in about 2003?
Dr Finley.Canada delivers health care on a provincial basis, and
so the regionalization process occurred in differing ways and differ-
ent scenarios in each province. The first to begin was British Co-
lumbia, which made a political decision in 2001 but did not
begin to enact it until about 2003. They were very organized about
it and moved different physicians to centralized centers and added
resources to those centers. Alberta was more informal and did not
have a formal regionalization process, but did move surgeons into
centralized locations. Ontario, with the largest population, has had
the biggest effect. About 2004, Ontario started the process, which is
still ongoing. That is probably why we see the largest change in
volume at the tail end because of the study period.
With regard to the numbers of lobectomies being performed, cer-
tainly the incidence of lung cancer is cresting in Canada and it only
goes up approximately 1% per year, so it wouldn’t explain the in-
crease in volume performed. I didn’t present the data, but over this
time frame, the number of pneumonectomies has decreased signif-
icantly from approximately 500 per year to approximately 250 per
year. So this would be a potential explanation—surgeons operating
on those patients are trying to do more limited resections. Alterna-
tively, patients are being referred to these high-volume centers
where they are getting multidisciplinary evaluation and not short
circuiting the surgeon and going directly into radiation or medical
oncologists. These are potential explanations.
Dr Colson. So was it done as a mandate or a financial incentive
if it was a high-volume versus low-volume center?
Dr Finley. Increased funding was involved in almost all the re-
gionalizations. Certainly in Ontario and British Columbia it is and
was an incentive-driven process, but in other provinces it was more
informally done without additional costs.
Dr Colson. The second question. You have stated that the de-
crease in IHM during this time period is likely related to the shift
of cases from low- to high-volume centers. However, given that
there is a 20% increase in the total number of lobectomies over
the course of your study, couldn’t it be that the increased percentage
of lobectomies done at high-volume centers is also just because
there are more cases for everyone, and therefore more mid-level
centers now qualify as high-volume centers as they cross the case
threshold of 60?
Dr Finley. Certainly there is a proportion of patients and facili-
ties that cross that threshold, but the majority of the effect we saw
was in the reduction of those low-volume centers going out of the
business, the reduction of the number of institutions performing it.
Dr Colson. There is an obvious dichotomy between the dra-
matic increase in mortality associated with an increasing number
of patients being treated in high-volume centers, but there is no
decrease in mortality associated with increasing the volume at
a specific hospital, correct?
Dr Finley. Yes.ery c October 2010
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SDr Colson. Given that the volume alone does not seem to be the
answer to everything, does your study reflect that the most impor-
tant benefit of regionalization may actually be the shifting of more
cases to low-mortality hospitals, and thus the overall decrease is
reflecting more cases done at these low-mortality hospitals, in
essence? Is there any insight that you have gained as to how to
make these high-volume centers really low-mortality centers?
Dr Finley. That is a good point, because there are a number of
small-volume centers that have excellent results with low mortal-
ities. However, on average the larger-volume hospitals deliver bet-
ter outcomes. Clearly a lot goes into the mortality of a patient
beyond the surgeon’s involvement. We are intimately involved in
our patients’ care, but a number of people become involved in their
outcomes, from the nursing ratios on the floor to the level of mon-
itoring the patients are undergoing to the ability of rescue. I think
one of the most influential articles I read in the last year was by
Amir Ghaferi, in The New England Journal of Medicine, who sug-
gested that the difference between a low-mortality hospital and
a high-mortality hospital had nothing to do with complication rates,
which were exactly the same. It was the ability of rescue; it was the
ability to pull those patients out of the fire once the morbidity oc-
curs. I think that is an area of research that needs to continue and
be ongoing, because if you don’t have 24-hour intensive care or
somebody in-house who is experienced with these patients, then
you can miss an opportunity to intervene.
Dr Colson. Thank you.
Dr Thomas Egan (Chapel Hill, NC). I enjoyed your presenta-
tion, but some of your conclusions are based on the accuracy of
coding. In the United States there is a financial incentive for hospi-
tals to code more, and I am curious to know across the provinces
during the time of your study, were there any financial incentives
and did you notice an increase in the number of ICD-9 codes
over time?
Dr Finley. There certainly was an increase in the Charlson co-
morbidity index as it relates to the ICD-9 and 10 codes. Hospitals
in some provinces are remunerated on the comorbidities of their pa-
tients, so there could be a slight trend there. That said, the Canadian
Institute of Health information goes back and examines the hospi-
tals on their coding systems and publishes regular reports on the ac-
curacy and validity of those reports, and it has actually been quite
reliable. That said, within our data it is internally consistent from
year to year, so I don’t think there was a drift in that way.
Dr Paul Waters (Greenwich, Conn). My question is a specific
question about a patient, John Smith. John Smith goes to a small-
volume hospital, say 10 cases per year, and dies. That hospital
now has a 10% mortality. He goes to a big hospital, bigger center,
say 100 cases per year, and dies. That is a 1% mortality. So it seems
that smaller centers are kind of inherently disadvantaged. It is a bit
like setting up a transplant program. If you do a small volume the
first year and have a mortality, you have a bad set of numbers.The Journal of Thoracic and CaYou probably mentioned this in your talk and I zoned out, but
I would like to hear your response to that.
Dr Finley. As I said, there are some tremendous small-volume
hospitals, and I think all of us worry about how to evaluate institu-
tions in a fair way, and that is why on a population basis we look at
all the hospitals lumped together. There are hospitals that do a very
good job, and trying to elucidate which hospitals actually have a sta-
tistically significant deviation from an acceptable threshold is diffi-
cult to do in real life, because a hospital that performs 10
lobectomies per year would require 4 or 5 years of evaluation to
know if they actually drifted off of statistically acceptable level.
So you are right, in a given year in a given hospital, it is unfair to
disadvantage them, but this is a population-based study, so we
are looking from 20,000 feet and lumping those groups together.
DrWaters. So that small hospital you looked at for 5 years, and
your threshold for acceptable was 6%, it is going to be an unaccept-
able center on the basis of those numbers, isn’t it, if it has a single
mortality per year? It is not an argument.
Dr Todd Demmy (Buffalo, NY). This regionalization was coin-
cident to the popularity rise in thoracoscopic lobectomy, which has
been shown to have a similar reduction in hospital stay, also a reduc-
tion in complications, which for a group who may be getting sicker
might have contributed to some of these outcomes. Did you look at
the proportions of thoracoscopic lobectomy to open in your groups?
Dr Finley. No, we were unable to do that, but I agree with you
that different technologies have an effect here. Minimally invasive
thoracic surgery and improvements in intensive care, perioperative
evaluation, and better staging all help, so we are picking patients
who do better. These could all have influenced the outcome.
Dr Valerie Rusch (New York, NY). The optimum care of these
patients is really a team effort, demanding excellent care from the
anesthesiologist team and nursing team. Do you have any way of
examining that in your analyses and has there been any regionali-
zation effort to develop specific nursing support services or the des-
ignation of thoracic anesthesia teams to optimize the care of these
patients that might also affect your results?
Dr Finley. It is difficult to evaluate from this study, but certainly
different provinces have enacted different systems of care as they
have taken on this process. In British Columbia, again, with the
concentration of specialized surgeons, there has been specialized
nursing and education in those centers. In Ontario, again with the
concentration of care and incentives to the hospital, those other vital
services are strengthened. There are guidelines that were published
in The Annals of Thoracic Surgery with recommendations for a sin-
gle-payer system, and they listed a number of criteria that would be
useful for those regionalized centers, including 24-hour interven-
tional radiology, intensive care, and ancillary staff such as special-
ized nursing and respiratory therapy. But I agree with you that
specialized nursing and specialized anesthesia go a long way to
improving that care.rdiovascular Surgery c Volume 140, Number 4 763
